(Q54546862)

English

The in vivo evaluation of active-site TOR inhibitors in models of BCR-ABL+ leukemia.

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22125070

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22125070

title

The in vivo evaluation of active-site TOR inhibitors in models of BCR-ABL+ leukemia. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22125070

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22125070

1 reference

Matthew R Janes

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22125070

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22125070

David A Fruman

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22125070

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22125070

language of work or name

English

0 references

publication date

1 January 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22125070

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22125070

number of pages

15

1 reference

based on heuristic

inferred from page(s)

published in

Methods in Molecular Biology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22125070

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22125070

volume

821

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22125070

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22125070

page(s)

251-265

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22125070

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22125070

Identifiers

DOI

10.1007/978-1-61779-430-8_15

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22125070

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22125070

PubMed publication ID

22125070

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22125070

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22125070

(Q54546862)

The in vivo evaluation of active-site TOR inhibitors in models of BCR-ABL+ leukemia.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)